Filter posts

GEN’s “Top 10” Session Picks for the 2013 BIO International Convention

As the industry moves forward in 2013, it again faces one of its regular bugaboos—uncertainty. …

Forbes 30 Under 30: Rising Biotech Stars at the 2013 BIO International Convention

For the second year in a row, Forbes magazine published a list of the most …

Show Me the Money: Reimbursement in an ACA World

A panel at the BIO CEO & Investor Conference focused on reimbursement discussed value from a …

Tracks & Attendees Put the “International” in the BIO International Convention

As the BIO International Convention celebrates its 20th year, there is no time like the present …

Word on the Street – Biotech Stocks Only Have Room to Go Up

The Opening Lunch Plenary at this year’s BIO CEO & Investor Conference was a lively …

Celgene CEO on New Multiple Myeloma Drug Approvals

Following on the heels of two big announcements in February, Celgene CEO Robert Hugin (one …

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

I was recently asked what the single biggest threat to the biotechnology industry is today.  …

2013 BIO International Convention Program Highlights

I’m thrilled to be attending the upcoming 2013 BIO International Convention that is coming to …

20th Anniversary of the BIO International Convention

Next year BIO will celebrate the 20th anniversary of the BIO International Convention April 22-25 …

BIO Investor Forum - Raring to Go: The Race to Treat Ultra-Rare Diseases

The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering …